Saffron
Saffron, licence 80088635: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nutrawise
- NPN or DIN-HM
- 80088635
- Status
- Active licence
- Licence date
- 10 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1000 mg Potency : 8.0 % Withanolides | 125.0 mg | Not calculated |
| Withania somnifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1000 mg Potency : 8.0 % Withanolides | 125.0 mg | Not calculated |
| Crocus sativus Source : Stigmates Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 45 mg Potency : 3.5 % Crocin | 15.0 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 3.0 % Rosavins | Not specified | Not calculated |
| Rhodiola rosea Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 700 mg Potency : 2.0 % Salidroside | 175.0 mg | Not calculated |
| Withania somnifera Source : Racine Potency : 2.0 % Withaferin A | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 2.0 % Withaferin A | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 32.0 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 32.0 % Withania oligosaccharides | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hydroxypropyl méthylcellulose, Dioxyde de silicium, Stéarate de magnésium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
(Used in Herbal Medicine) (as an adaptogen) (to) help(s) (to) temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness). (Used in Herbal Medicine) (to) help(s) support cognitive function (such as mental focus and mental stamina). Provides antioxidants. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps promote positive mood. Helps reduce temporary nervousness. Helps promote relaxation. Helps support emotional wellness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you have bipolar disorder or bipolar spectrum disorder, do not use this product. Some people may experience anxiety/nervousness, increased appetite, nausea and headache, in which case, discontinue use.
- Contre-indications
Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. If you experience irritability or insomnia, discontinue use. Do not use if you are taking blood thinners/anticoagulants or have a bleeding disorder. Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use.
Source
Official Health Canada record, licence 80088635
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.